{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:35:37Z","timestamp":1785404137896,"version":"3.56.0"},"reference-count":45,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007414","name":"Qassim University","doi-asserted-by":"publisher","award":["QU-APC-2026"],"award-info":[{"award-number":["QU-APC-2026"]}],"id":[{"id":"10.13039\/501100007414","id-type":"DOI","asserted-by":"publisher"}]},{"award":["QU-APC-2026"],"award-info":[{"award-number":["QU-APC-2026"]}],"id":[{"id":"https:\/\/ror.org\/01wsfe280","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Polycythemia vera (PV) is a JAK2V617F-driven myeloproliferative neoplasm characterized by erythroid expansion, increased thrombotic risk, and heterogeneous clinical outcomes. Although prior studies have described key transcriptional abnormalities\u2014including Janus kinase\u2013signal transducer and activator of transcription (JAK\u2013STAT) hyperactivation and chronic myeloinflammation\u2014most have examined single hematopoietic compartments. A multi-compartment approach may reveal conserved and lineage-specific disease-associated transcriptional programs. Here, an integrated, multi-compartment transcriptomic analysis of publicly available microarray datasets was performed, spanning bone marrow (BM) CD34+ progenitors, peripheral blood (PB) CD34+ progenitors, and whole blood from PV patients and healthy controls, with independent validation in neutrophils. Differential gene expression, pathway enrichment, and protein\u2013protein interaction network analyses were used to delineate conserved versus compartment-specific transcriptional programs and to evaluate persistence of progenitor-derived signatures into mature myeloid cells. Across compartments, PV demonstrated consistent enrichment of inflammatory, interferon, and JAK\u2013STAT-associated pathways despite limited overlap at the individual gene level, indicating that core disease processes are maintained through lineage- and differentiation-stage-specific transcriptional reprogramming. Network analysis identified highly connected hub genes, which were used to derive a single-sample gene set enrichment (ssGSEA) signature. This signature showed strong diagnostic performance across cohorts; remained enriched in PV neutrophils; and correlated with platelet count, indolent disease status, and reduced levels in post-splenectomy patients. Together, these findings support a model in which PV is driven by stable, progenitor-derived inflammatory programs that persist across myeloid differentiation while incorporating compartment-specific adaptations, and highlight the value of multi-compartment, network-based approaches for translational biomarker development.<\/jats:p>","DOI":"10.3390\/ijms27104580","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:30:51Z","timestamp":1779280251000},"page":"4580","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-Compartment Transcriptomics Identifies a Persistent Inflammatory Program and a Network-Derived Diagnostic Signature in Polycythemia Vera"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8472-0440","authenticated-orcid":false,"given":"Abdulmohsen M.","family":"Alruwetei","sequence":"first","affiliation":[{"name":"Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51431, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/ajh.27002","article-title":"Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management","volume":"98","author":"Tefferi","year":"2023","journal-title":"Am. J. Hematol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1158\/2159-8290.CD-14-0736","article-title":"JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response","volume":"5","author":"Kleppe","year":"2015","journal-title":"Cancer Discov."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41572-025-00608-3","article-title":"Polycythaemia vera","volume":"11","author":"Harrison","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Todor, S.B., and Mihaila, R.G. (2025). Cytokine Landscapes, Immune Dysregulation, and Treatment Perspectives in Philadelphia-Negative Myeloproliferative Neoplasms: A Narrative Review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14176328"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"eaan8292","DOI":"10.1126\/scitranslmed.aan8292","article-title":"Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms","volume":"10","author":"Wolach","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.3324\/haematol.2021.278499","article-title":"The possible role of mutated endothelial cells in myeloproliferative neoplasms","volume":"106","author":"Farina","year":"2021","journal-title":"Haematologica"},{"key":"ref_8","first-page":"79","article-title":"JAK2 mutations in polycythemia vera: From molecular origins to inflammatory pathways and clinical implications","volume":"17","author":"Bellosillo","year":"2025","journal-title":"memo-Mag. Eur. Med. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s00277-014-2205-y","article-title":"Polycythemia vera disease burden: Contributing factors, impact on quality of life, and emerging treatment options","volume":"93","author":"Stein","year":"2014","journal-title":"Ann. Hematol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood-2016-10-695940","article-title":"Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms","volume":"129","author":"Vainchenker","year":"2017","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1158\/1078-0432.CCR-10-1092","article-title":"Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617F","volume":"16","author":"Buzzai","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa1403141","article-title":"Two clinical phenotypes in polycythemia vera","volume":"371","author":"Spivak","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1182\/blood-2019-128301","article-title":"Integrated Genomic-Transcriptomic Study Highlights Accumulation of Genetic Variants and Activation of Inflammatory Pathways","volume":"134","author":"Kandarpa","year":"2019","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3892\/ol.2021.12465","article-title":"Gene expression profiling of CD34(+) cells from patients with myeloproliferative neoplasms","volume":"21","author":"Sharma","year":"2021","journal-title":"Oncol. Lett."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1007\/s00277-021-04615-8","article-title":"Early and late stage MPN patients show distinct gene expression profiles in CD34(+) cells","volume":"100","author":"Baumeister","year":"2021","journal-title":"Ann. Hematol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Guijarro-Hern\u00e1ndez, A., and Vizmanos, J.L. (2023). Transcriptomic comparison of bone marrow CD34\u2009+\u2009cells and peripheral blood neutrophils from ET patients with JAK2 or CALR mutations. BMC Genom. Data, 24.","DOI":"10.1186\/s12863-023-01142-5"},{"key":"ref_17","unstructured":"Baumeister, J., Chatain, N., Hubrich, A., Mai\u00e9, T., Costa, I., Denecke, B., Han, L., K\u00fcstermann, C., Sontag, S., and Ser\u00e9, K. (2026, February 16). Gene Expression Data from BMCD34+ and PBCD34+ Cells from JAK2V617F-Positive MPN Patients vs. Healthy Controls. Gene Expression Omnibus (GEO), GSE136335, Available online: https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE136335."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1182\/blood-2019-131909","article-title":"Hypoxia Inducible Factors\u2019 Transcriptional Activity in Polycythemia Vera","volume":"134","author":"Song","year":"2019","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Tillmann, S., Olschok, K., Schr\u00f6der, S.K., B\u00fctow, M., Baumeister, J., Kalmer, M., Preu\u00dfger, V., Weinbergerova, B., Kricheldorf, K., and Mayer, J. (2021). The Unfolded Protein Response Is a Major Driver of LCN2 Expression in BCR-ABL- and JAK2V617F-Positive MPN. Cancers, 13.","DOI":"10.3390\/cancers13164210"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"37099","DOI":"10.1038\/srep37099","article-title":"Comprehensive Gene expression meta-analysis and integrated bioinformatic approaches reveal shared signatures between thrombosis and myeloproliferative disorders","volume":"6","author":"Jha","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_21","unstructured":"Bj\u00f6rlin, M., Ljungberg, E., Norberg, W.N., Ahlstrand, E., \u00c5str\u00f6m, M., and Ramstr\u00f6m, S. (2025). Platelet FCGR2A-Dependent Prothrombotic Signaling in Patients with JAK2V617F+ Polycythemia Vera, The European Hematology Association Congresses."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.1073\/pnas.0601462103","article-title":"The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation","volume":"103","author":"Jamieson","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.exphem.2012.05.011","article-title":"Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis","volume":"40","author":"Skov","year":"2012","journal-title":"Exp. Hematol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/bloodadvances.2025018011","article-title":"Toward new therapy end points in polycythemia vera: Targeting clonal and inflammatory pathways","volume":"10","author":"Barbui","year":"2026","journal-title":"Blood Adv."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1002\/cncr.35559","article-title":"New advances in the role of JAK2 V617F mutation in myeloproliferative neoplasms","volume":"130","author":"Zhang","year":"2024","journal-title":"Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Hasselbalch, H.C., Thomassen, M., Riley, C.H., Kj\u00e6r, L., Larsen, T.S., Jensen, M.K., Bjerrum, O.W., Kruse, T.A., and Skov, V. (2014). Whole blood transcriptional profiling reveals deregulation of oxidative and antioxidative defence genes in myelofibrosis and related neoplasms. Potential implications of downregulation of Nrf2 for genomic instability and disease progression. PLoS ONE, 9, Erratum in PLoS ONE 2015, 10, e0118049. https:\/\/doi.org\/10.1371\/journal.pone.0118049.","DOI":"10.1371\/journal.pone.0112786"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"453020","DOI":"10.1155\/2015\/453020","article-title":"Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms","volume":"2015","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1182\/blood-2013-10-463646","article-title":"Thrombosis: Tangled up in NETs","volume":"123","author":"Martinod","year":"2014","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1038\/s41598-020-63680-7","article-title":"Differential cytokine network profile in polycythemia vera and secondary polycythemia","volume":"10","author":"Cacemiro","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.leukres.2012.10.020","article-title":"Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?","volume":"37","author":"Hasselbalch","year":"2013","journal-title":"Leuk. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00277-026-06787-7","article-title":"Evaluating inflammatory markers in distinguishing polycythemia Vera from secondary polycythemia: A prospect for novel diagnostic marker","volume":"105","author":"Khaksari","year":"2026","journal-title":"Ann. Hematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41375-025-02569-8","article-title":"Malignant JAK-signaling: At the interface of inflammation and malignant transformation","volume":"39","author":"Perner","year":"2025","journal-title":"Leukemia"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11899-019-00508-w","article-title":"Key Role of Inflammation in Myeloproliferative Neoplasms: Instigator of Disease Initiation, Progression. and Symptoms","volume":"14","author":"Blackmon","year":"2019","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Skov, V., Burton, M., Thomassen, M., Stauffer Larsen, T., Riley, C.H., Brinch Madelung, A., Kj\u00e6r, L., Bondo, H., Stamp, I., and Ehinger, M. (2016). A 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic Myelofibrosis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0161570"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1080\/10428194.2016.1262032","article-title":"The impact of interferon-alpha2 on HLA genes in patients with polycythemia vera and related neoplasms","volume":"58","author":"Skov","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41408-017-0010-2","article-title":"CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles","volume":"7","author":"Zini","year":"2017","journal-title":"Blood Cancer J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1182\/blood-2014-02-554634","article-title":"Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis","volume":"123","author":"Rampal","year":"2014","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7.12.1","DOI":"10.1002\/0471250953.bi0712s22","article-title":"Using GenePattern for Gene Expression Analysis","volume":"22","author":"Kuehn","year":"2008","journal-title":"Curr. Protoc. Bioinform."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"W755","DOI":"10.1093\/nar\/gkq405","article-title":"AltAnalyze and DomainGraph: Analyzing and visualizing exon expression data","volume":"38","author":"Emig","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Chen, C., Grennan, K., Badner, J., Zhang, D., Gershon, E., Jin, L., and Liu, C. (2011). Removing batch effects in analysis of expression microarray data: An evaluation of six batch adjustment methods. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0017238"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Heberle, H., Meirelles, G.V., da Silva, F.R., Telles, G.P., and Minghim, R. (2015). InteractiVenn: A web-based tool for the analysis of sets through Venn diagrams. BMC Bioinform., 16.","DOI":"10.1186\/s12859-015-0611-3"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"20560","DOI":"10.1038\/s41598-020-76603-3","article-title":"VolcaNoseR is a web app for creating, exploring, labeling and sharing volcano plots","volume":"10","author":"Goedhart","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database Hallmark Gene Set Collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Tang, D., Chen, M., Huang, X., Zhang, G., Zeng, L., Wu, S., and Wang, Y. (2023). SRplot: A free online platform for data visualization and graphing. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0294236"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"W234","DOI":"10.1093\/nar\/gkz240","article-title":"NetworkAnalyst 3.0: A visual analytics platform for comprehensive gene expression profiling and meta-analysis","volume":"47","author":"Zhou","year":"2019","journal-title":"Nucleic Acids Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4580\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T12:35:10Z","timestamp":1779280510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/10\/4580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["ijms27104580"],"URL":"https:\/\/doi.org\/10.3390\/ijms27104580","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}